PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

PetMed Express, Inc.

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from PetMed Express, Inc.'s yearly results (2022–2026), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.

What stands out

  • Cash Locked Ratio: Money owed to suppliers is larger than money owed by customers plus stock: $16 per $100 of sales comes from others' credit, against $7 from others' credit three years earlier. Less money tied up than 95% of Healthcare companies in United States.
  • Steadiness Ratio: Sales grew in 1 of the last 3 years; profit grew in 0 of 3. Less steady than 86% of Healthcare companies in United States.
  • Cash Cushion Ratio: Cash, after subtracting all debt, equals 82% of its market value (net cash). Higher than 85% of Healthcare companies in United States.

Cash quality

Profit Cash Ratio

—

Loss-making or profit too small

Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.

Self-Funding Ratio

0.3×

Over the last 3 years its own operating cash paid for 26% of its investment spending (capex); the rest came from other sources such as borrowing, cash reserves or new shares.

Higher than 65% of Healthcare companies in United States.

Cash Locked Ratio

−$16

Money owed to suppliers is larger than money owed by customers plus stock: $16 per $100 of sales comes from others' credit, against $7 from others' credit three years earlier.

Less money tied up than 95% of Healthcare companies in United States.

Growth quality

Steadiness Ratio

1/3 · 0/3

Sales grew in 1 of the last 3 years; profit grew in 0 of 3.

Less steady than 86% of Healthcare companies in United States.

Growth Efficiency Ratio

—

Sales fell 34%

Sales fell 34% in 3 years, so extra profit per extra sales cannot be measured.

Asset Productivity Ratio

-34% / -55%

In 3 years sales changed by -34% while total assets changed by -55%. Sales grew faster than assets.

Balance-sheet strength

Debt Due Cover Ratio

-57.6×

Operating cash was negative last year, while some debt falls due within a year.

Lower than 75% of Healthcare companies in United States.

Cash Cushion Ratio

+82%

Cash, after subtracting all debt, equals 82% of its market value (net cash).

Higher than 85% of Healthcare companies in United States.

Tangible Assets Ratio

93%

Of every $100 the company owns, $93 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

More tangible than 67% of Healthcare companies in United States.

Tangible Net Worth Ratio

81%

Of every $100 of net worth, $81 is tangible; the rest is goodwill and other intangibles, often from buying other companies.

More tangible than 62% of Healthcare companies in United States.

Shareholders

Shareholder Slice Ratio

+2%

Share count rose 2% in 3 years, so each share's slice of the company became smaller.

Smaller rise in share count than 81% of Healthcare companies in United States.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (10)

PetMed Express, Inc. made a loss over the last year. PetMed Express, Inc. owes $0.64 for every $1 it owns.

Compared with Healthcare companies in United States · latest annual results Mar 2026.

P/E ratio

Loss

PetMed Express, Inc. made a loss over the last year, so its P/E ratio is not meaningful.

P/B ratio

1.11

The share price is 1.11 times PetMed Express, Inc.'s book value per share, lower than 76% of Healthcare companies in United States.

Market cap

$26 M

The total market value of all of PetMed Express, Inc.'s shares at today's price (share price × number of shares), smaller than 81% of Healthcare companies in United States. PosiCap size class: Micro Cap.

Net worth (book value)

$23 M

What PetMed Express, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

$1.06

Net worth divided by the number of shares. The share price of $1.18 is 1.1 times this, which is the P/B above.

Return on equity (ROE)

-78.6%

PetMed Express, Inc. lost 78.6% of its shareholders' money over the last year, lower than 65% of Healthcare companies in United States.

Owes vs Owns

0.64×

PetMed Express, Inc. owes $0.64 for every $1 it owns (moderate), higher than 67% of Healthcare companies in United States.

Dividend yield

None

PetMed Express, Inc. does not currently pay a dividend.

Profit margin

-32.0%

PetMed Express, Inc. lost $32 for every $100 of revenue.

Cash vs debt

Net cash

PetMed Express, Inc. held $21 M more cash than debt (net cash) at Mar 2026.

Questions

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For PetMed Express, Inc.: $26 M ÷ $23 M (30 Jun 2026) = 1.1.

What is PetMed Express, Inc.'s return on equity?

PetMed Express, Inc. lost 78.6% of its shareholders' money over the last year, lower than 65% of Healthcare companies in United States.

How much does PetMed Express, Inc. owe compared with what it owns?

PetMed Express, Inc. owes $0.64 for every $1 it owns (moderate), higher than 67% of Healthcare companies in United States.

Does PetMed Express, Inc. pay a dividend?

No. PetMed Express, Inc. does not currently pay a dividend.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.